{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "regularMarketChangePercent": -1.9367491, "regularMarketPrice": 8.0, "exchange": "STO", "shortName": "Oncopeptides AB", "longName": "Oncopeptides AB (publ)", "messageBoardId": "finmb_12930666", "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "se_market", "marketState": "REGULAR", "esgPopulated": false, "sharesOutstanding": 90368704, "bookValue": 3.121, "fiftyDayAverage": 10.34146, "fiftyDayAverageChange": -2.3414602, "fiftyDayAverageChangePercent": -0.22641486, "twoHundredDayAverage": 16.41537, "twoHundredDayAverageChange": -8.415371, "twoHundredDayAverageChangePercent": -0.51265186, "marketCap": 722949632, "forwardPE": -2.7210884, "priceToBook": 2.563281, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1487750400000, "priceHint": 2, "regularMarketChange": -0.15799999, "regularMarketTime": 1684144834, "regularMarketDayHigh": 8.194, "regularMarketDayRange": "7.922 - 8.194", "regularMarketDayLow": 7.922, "regularMarketVolume": 60193, "regularMarketPreviousClose": 8.158, "bid": 8.0, "ask": 8.012, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 8.158, "averageDailyVolume3Month": 571858, "averageDailyVolume10Day": 660901, "fiftyTwoWeekLowChange": 0.29799986, "fiftyTwoWeekLowChangePercent": 0.03869123, "fiftyTwoWeekRange": "7.702 - 50.84", "fiftyTwoWeekHighChange": -42.84, "fiftyTwoWeekHighChangePercent": -0.84264356, "fiftyTwoWeekLow": 7.702, "fiftyTwoWeekHigh": 50.84, "earningsTimestamp": 1691665140, "earningsTimestampStart": 1691665140, "earningsTimestampEnd": 1691665140, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.71, "epsForward": -2.94, "symbol": "ONCO.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Vastra Tradgardsgatan 15", "city": "Stockholm", "zip": "111 53", "country": "Sweden", "phone": "46 86 15 20 40", "website": "https://www.oncopeptides.com/sv", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Oncopeptides AB (publ), a biotech company, engages in the commercialization, and research and development of treatments for difficult-to-treat hematological diseases in the United States, Europe, and internationally. Its lead product candidate is melflufen, a drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jakob  Lindberg Med. Lic", "age": 50, "title": "Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 7260000, "fmt": "7.26M", "longFmt": "7,260,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Monica  Shaw M.D.", "age": 43, "title": "Chief Exec. Officer", "yearBorn": 1979, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Rolf  Larsson M.D., Ph.D.", "title": "Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Rolf  Lewensohn M.D., Ph.D.", "title": "Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Joachim  Gullbo M.D., MSc Pharm, Ph.D.", "title": "Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kristina  Luthman Ph.D.", "title": "Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Hans  Ehrsson M.D.", "title": "Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Peter  Nygren", "age": 63, "title": "Founder", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Holger  Lembrer M.Sc.", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1984, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Eva  Nordstr\u00f6m M.Sc., MSc Pharm", "age": 52, "title": "COO & Deputy MD", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}